Imago BioSciences

0 followers

‌

Our scientific initial efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow using an LSD1 inhibitor

Industries

Biotechnology, Education

Headquarters

San Carlos, United States

Employees

51-200

Links

Org chart

Hugh Y. Rienhoff, Jr.

CEO

Hugh Y. Rienhoff, Jr.

Collapse

Michael Arenberg

Chief Operating & Business Officer

Laura G. Eichorn

CFO

Wan-Jen Hong

Chief Medical Officer

Amy E. Tapper

SVP, Non-Clinical & CMC

Allison Anderson, MAS

Head of People & Talent

Amy Tapper

Chief Technology Officer

Cassandra Celatka

Exec. Director, Drug Discovery and Development

Enoch Kariuki

Board Director, Audit Chair

Ian Houts

Senior Director Supply Chain

Joshua Giguere

Director, Drug Substance CMC

Maria Kleppe

Senior Director, Scientific Discovery

Nivedita Namdev

Senior Director, Medicinal Chemistry

Randy Corley

Director, Clinical Quality Compliance

Sahar Wazen

Senior Quality Management System (QMS) Manager

Sangati Gandhi

Director Program Management

Stephanie Roland

Vice President Regulatory Affairs

Xi Chen

Director, Analytical Chemistry

Philippa Quy

Clinical Trial Manager

Teams

+12

Clinical and Scientific Operations

15 members

Directors Team

9 members

Leadership Team

5 members

Finance & Accounting

4 members

Technical Team

3 members

Similar companies

Genesis Therapeutics

1 follower

Sonoma Biotherapeutics

1 follower

Adaptive Biotechnologies

13 followers

Regeneron

92 followers

brightwheel

11 followers

Artiva Biotherapeutics

1 follower

Amyris

8 followers

Idexx Laboratories

7 followers

Cypher Learning

1 follower

BridgeBio

2 followers

Southern Poverty Law Center

2 followers

Explore companies